, Volume 42, Supplement 3, pp 22–24 | Cite as

Microbiological Conclusions

  • Ronald N. Jones


Cefaclor Cefixime Neisseria Gonorrhoeae Generation Cephalosporin Cefpodoxime 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Borin M. A review of the pharmacokinetics of cefpodoxime proxetil. Drugs 42 (Suppl. 3): 13–21, 1991PubMedCrossRefGoogle Scholar
  2. Fujii R. Clinical trials of cefpodoxime proxetil suspension in paediatrics. Drugs 42 (Suppl. 3): 57–60, 1991PubMedCrossRefGoogle Scholar
  3. Fujimoto K, Ishihara S, Yonagisawa H, Ide J, Nakayama E, et al. Studied on orally active cephalosporin esters. Journal of Antibiotics 40: 370–384, 1987PubMedCrossRefGoogle Scholar
  4. Jones R. Antimicrobial activity, spectrum and pharmacokinetics of old and new orally administered cephems. Antimicrobial Newsletter 5: 1–7, 1988CrossRefGoogle Scholar
  5. Jones R, Barry A. In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition. Diagnostic Microbiology and Infectious Disease 8: 245–249, 1987PubMedCrossRefGoogle Scholar
  6. Jones R, Barry A. Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807). Antimicrobial Agents and Chemotherapy 32: 443–449, 1988PubMedCrossRefGoogle Scholar
  7. Jones R, Barry A, Pfaller M, Allen S, Ayers L, et al. Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control. Diagnostic Microbiology and Infectious Disease 9: 59–63, 1988PubMedCrossRefGoogle Scholar
  8. Richmond M, Sykes R. The beta-lactamases of gram-negative bacteria and their possible physiological role. Advances in Microbial Physiology 9: 31, 1973PubMedCrossRefGoogle Scholar
  9. Tack KJ, Wilks NE, Semerdjian G, Frazier CH, Shirin K, et al. Cefpodoxime proxetil in the treatment of skin and soft tissue infections. Drugs 42 (Suppl. 3): 51–56, 1991PubMedCrossRefGoogle Scholar
  10. Utsui Y, Inoue M, Mitsuhashi S. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 31: 1085–1092, 1987PubMedCrossRefGoogle Scholar
  11. Wiedemann B, Luhmer E, Zühlsdorf MT. Microbiological evaluation of cefpodoxime proxetil. Drugs 42 (Suppl. 3): 6–12, 1991PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1991

Authors and Affiliations

  • Ronald N. Jones
    • 1
  1. 1.Department of PathologyUniversity of Iowa Hospitals and ClinicsIowa CityUSA

Personalised recommendations